Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation Nov 20, 2025 09:00AM
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules Nov 3, 2025 09:00AM
Altamira Therapeutics reports 33% decrease in operating loss for first half 2025 Aug 29, 2025 07:30AM
Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results Aug 29, 2025 07:30AM
Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025 Aug 26, 2025 04:00PM


Jul 15, 2025 09:00AM Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine